3-aminoisobutyric acid has been researched along with Cardiac Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisawa, Y; Fujito, T; Furuhashi, M; Katano, S; Katayose, M; Kouzu, H; Kuno, A; Nagano, N; Nagaoka, R; Nishikawa, R; Numazawa, R; Ohori, K; Ohwada, W; Sato, T; Yamano, K; Yano, T | 1 |
1 other study(ies) available for 3-aminoisobutyric acid and Cardiac Failure
| Article | Year |
|---|---|
Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors.
Topics: Aged; Aminoisobutyric Acids; Diabetes Mellitus, Type 2; Female; Glucose; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2022 |